TOTI, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 15.393
AS - Asia 2.501
EU - Europa 1.752
SA - Sud America 333
Continente sconosciuto - Info sul continente non disponibili 263
AF - Africa 28
OC - Oceania 3
Totale 20.273
Nazione #
US - Stati Uniti d'America 15.239
SG - Singapore 1.211
CN - Cina 479
IT - Italia 368
BR - Brasile 259
HK - Hong Kong 256
RU - Federazione Russa 254
DE - Germania 227
VN - Vietnam 196
FI - Finlandia 177
UA - Ucraina 170
IE - Irlanda 148
GB - Regno Unito 114
BD - Bangladesh 105
FR - Francia 76
CA - Canada 70
JP - Giappone 62
SE - Svezia 54
IN - India 52
NL - Olanda 41
KR - Corea 36
PL - Polonia 34
AR - Argentina 25
ES - Italia 21
ID - Indonesia 18
MX - Messico 18
AT - Austria 16
BE - Belgio 13
CO - Colombia 13
IQ - Iraq 13
EC - Ecuador 11
ZA - Sudafrica 11
CZ - Repubblica Ceca 9
PR - Porto Rico 9
TH - Thailandia 9
TR - Turchia 9
CR - Costa Rica 8
GP - Guadalupe 8
NI - Nicaragua 8
VE - Venezuela 8
CH - Svizzera 7
TT - Trinidad e Tobago 7
CL - Cile 6
HN - Honduras 6
NP - Nepal 6
AZ - Azerbaigian 5
CW - ???statistics.table.value.countryCode.CW??? 5
JM - Giamaica 5
RO - Romania 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
IL - Israele 4
KE - Kenya 4
LT - Lituania 4
SV - El Salvador 4
TM - Turkmenistan 4
AU - Australia 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
EU - Europa 3
GT - Guatemala 3
LB - Libano 3
MY - Malesia 3
PH - Filippine 3
PY - Paraguay 3
UY - Uruguay 3
UZ - Uzbekistan 3
BB - Barbados 2
DZ - Algeria 2
EE - Estonia 2
GR - Grecia 2
HR - Croazia 2
JO - Giordania 2
KZ - Kazakistan 2
MA - Marocco 2
PE - Perù 2
PK - Pakistan 2
PT - Portogallo 2
TN - Tunisia 2
TW - Taiwan 2
A1 - Anonimo 1
AG - Antigua e Barbuda 1
AM - Armenia 1
AO - Angola 1
AW - Aruba 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CV - Capo Verde 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
HU - Ungheria 1
IM - Isola di Man 1
IR - Iran 1
KG - Kirghizistan 1
KW - Kuwait 1
MD - Moldavia 1
ML - Mali 1
MV - Maldive 1
NG - Nigeria 1
Totale 20.015
Città #
Wilmington 3.579
Woodbridge 3.462
Houston 3.260
Singapore 543
Ashburn 504
Fairfield 453
Ann Arbor 317
San Jose 312
Chandler 281
Hong Kong 250
Seattle 201
Beijing 188
Cambridge 180
Dublin 143
Jacksonville 142
Helsinki 135
Council Bluffs 122
Santa Clara 122
New York 119
Medford 109
Rome 89
Zhengzhou 83
Los Angeles 78
Dearborn 71
The Dalles 71
Ho Chi Minh City 64
Tokyo 57
Lawrence 51
Buffalo 48
Moscow 47
Chicago 42
Hanoi 41
North Bergen 40
San Diego 35
São Paulo 33
Lauterbourg 31
Boardman 27
Denver 27
Dallas 23
Atlanta 22
Milan 22
Montreal 22
Mülheim 21
Orem 21
Shanghai 21
Frankfurt am Main 19
Menlo Park 19
Chennai 18
Munich 18
Brooklyn 16
Phoenix 16
London 15
San Francisco 15
Warsaw 15
Manchester 13
Nanjing 13
Toronto 13
Verona 13
Creede 12
Nuremberg 12
Guangzhou 11
Mountain View 11
Redondo Beach 11
Poplar 10
Redwood City 10
Salt Lake City 10
Jakarta 9
Jersey City 9
Johannesburg 9
Kraków 9
Rio de Janeiro 9
San Mateo 9
Vienna 9
Brasília 8
Brussels 8
Madrid 8
Managua 8
Quito 8
Stockholm 8
Bologna 7
Cagliari 7
Charlotte 7
Da Nang 7
Lappeenranta 7
Norwalk 7
Nürnberg 7
Palo Alto 7
San José 7
Szczecin 7
Amsterdam 6
Belo Horizonte 6
Falls Church 6
Hefei 6
Mexico City 6
Naples 6
San Juan 6
Seoul 6
Turin 6
Washington 6
Bangkok 5
Totale 16.045
Nome #
Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. 558
Successful management of a same-day emergency delivery and liver transplant in a 27 weeks pregnant woman with fulminant hepatic failure. 512
Deep vein thrombosis as debut of cytomegalovirus infection associated with type ii cryoglobulinemia, with antierythrocyte specificity in a kidney transplant recipient: A case report 512
Hepatitis C virus recurrence and immunosuppression-free state after liver transplantation. 510
Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: Two case reports 505
Use of mycophenolate mofetil in liver transplantation: a literature review. 499
Impact of immunosuppression minimization and withdrawal in long-term hepatitis C virus liver transplant recipients 496
Marginal donors in liver transplantation. 487
Primary yolk sac tumor of the liver: incidental finding in a patient transplanted for hepatocellular carcinoma 484
Ferguson hemorrhoidectomy with radiofrequency versus classic diathermy 481
596 478
Steroid-free immunosuppression after liver transplantation does not increase the risk of graft fibrosis. 473
Interposition of the right colic angle between the liver and thoracic wall: an unusual cause of massive rectal bleeding following percutaneous biopsy in a liver transplant recipient. 469
Management of spermatic cord liposarcoma in renal transplant recipients: case report 459
TUDCA prevents cholestasis and canalicular damage induced by ischemia-reperfusion injury in the rat, modulating PKC alpha-ezrin pathway 458
Complete hbv prophylaxis withdrawal in HBsAg-positive liver transplant recipients after long-term minimal immunosuppression 453
Long-term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis C 452
Interposition of the right colic angle between the liver and thoracic wall: An unusual cause of massive rectal bleeding following percutaneous biopsy in a liver transplant recipient 448
Liver transplantation in the presence of portal vein thrombosis: report from a single center. 439
Liver transplantation for the treatment of nodular regenerative hyperplasia 435
Side-to-side caval anastomosis in a patient receiving a liver graft from a marginal donor with situs inversus totalis 434
The Tor Vergata weaning of immunosuppression protocols in stable hepatitis C virus liver transplant patients: the 10-year follow-up 431
Radiofrequency-assisted right hemihepatectomy by using a new incremental bipolar generator combined with liver hanging maneuver. 430
One-shot versus multidose perioperative antibiotic prophylaxis after kidney transplantation: A randomized, controlled clinical trial 430
Ferguson Hemorrhoidectomy with Radiofrequency versus Classic Diathermy 430
Liver transplantation in the presence of portal vein thrombosis: Report from a single center 417
Submucosal hemorroidectomy with radiofrequency bistoury 395
Ab initio Everolimus-based Versus Standard Calcineurin Inhibitor Immunosuppression Regimen in Liver Transplant Recipients 392
Switch from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in kidney transplantation. 389
Liver transplantation for hepatitis B and C virus-related cirrhosis: mid-term results 377
Treatment of Multiple Actinic Keratosis and Field of Cancerization with Topical Piroxicam 0.8% and Sunscreen 50+ in Organ Transplant Recipients: A Series of 10 Cases 365
An unusual duodenal polyp causing anemia in a liver-transplanted patient 361
Longterm Survival and Cost-Effectiveness of Immunosuppression Withdrawal After Liver Transplantation 352
Submucosal hemorroidectomy with radiofrequency bistoury 313
Liver transplantation with a normothermic machine preserved fatty nonagenarian liver: A case report 309
Renal Function, Adherence and Quality of Life Improvement After Conversion From Immediate to Prolonged-Release Tacrolimus in Liver Transplantation: Prospective Ten-Year Follow-Up Study 289
Rare malignant glomus tumor of the stomach with liver metastases 252
Everolimus and enteric-coated mycophenolate sodium Ab initio after liver transplantation: Midterm results 244
Evaluation of Contrast-Enhanced Intraoperative Ultrasound in the Detection and Management of Liver Lesions in Patients with Hepatocellular Carcinoma 223
De novo malignancies after liver transplantation: The effect of immunosuppression-personal data and review of literature 221
Endovascular Mechanical Thromboaspiration of Right Hepatic Arterial Thrombosis After Liver Transplantation 202
Increased cancer risk in patients undergoing dialysis: A population-based cohort study in North-Eastern Italy 199
Survival after the diagnosis of de novo malignancy in liver transplant recipients 188
Recurrence of Hepatitis B Infection in Liver Transplant Patients Receiving Long-Term Hepatitis B Immunoglobulin Prophylaxis 182
The hamletic dilemma of patients waiting for kidney transplantation during the COVID-19 pandemic: to accept or not to accept (an organ offer)? 147
Prevalent use of Combined Prophylaxis of Hepatitis B after liver transplantation in Italy: Results of a national survey in a large cohort 138
Serum Levels of Granulocyte-Macrophage-colony-stimulating Factor and Stem-cell Factor During Liver Regeneration after Partial Hepatectomy in Humans 133
Imaging findings of a case of peliosis hepatis mimicking malignancies 128
Risk of virus and non-virus related malignancies following immunosuppression in a cohort of liver transplant recipients. Italy, 1985–2014 126
Effects of Anti-COVID-19 Vaccination and Pre-Exposure Prophylaxis with Tixagevimab-Cilgavimab in Kidney and Liver Transplant Recipients 125
Hepatocellular carcinoma and the risk of de novo malignancies after liver transplantation – a multicenter cohort study 125
The Enhanced Recovery after Surgery (ERAS) Pathway Is a Safe Journey for Kidney Transplant Recipients during the “Extended Criteria Donor” Era 122
Safety and efficacy of simultaneous liver transplantation and sleeve gastrectomy in morbid obese patients with end-stage liver disease: the LT-SG study 119
Mechanism, potential, and concerns of immunotherapy for hepatocellular carcinoma and liver transplantation 116
Successful clinical and virological outcomes of liver transplantation for HDV/HBV-related disease after long-term discontinuation of hepatitis B immunoglobulins 112
The Enhanced Recovery After Surgery Pathway Is Safe, Feasible and Cost-Effective in Delayed Graft Function After Kidney Transplant 112
Intraductal Papillary Neoplasms of the Bile Duct: Clinical Case Insights and Literature Review 107
Liver transplantation performed in a SARS-CoV-2 positive hospitalized recipient using a SARS-CoV-2 infected donor 107
MR protocol optimization for hepatobiliary phase imaging with Gd-EOB-DTPA at 1.5 T: comparison between breath-hold T1-weighted and high-resolution navigated 3D T1-weighted sequences 102
The Effects of Sustained Immunosuppression Withdrawal After Liver Transplantation on Metabolic Syndrome 98
Towards tolerance in liver transplantation 98
The efficacy and safety of mammalian target of rapamycin inhibitors ab initio after liver transplantation without corticosteroids or induction therapy 97
Urological Complications in Kidney Transplant Recipients: Analysis of the Risk Factors and Impact on Transplant Outcomes in the Era of “Extended Criteria Donors” 91
The management of immunosuppression in kidney transplant recipients with COVID-19 disease: an update and systematic review of the literature 88
Feasibility and cost effectiveness of ambulatory laparoscopic cholecystectomy. A retrospective cohort study 88
Benign disease and unexpected histologocal findings after pancreaticoduodenectomy: The role of endoscopic ultrasound fine needle aspiration 80
Health economics aspects of kidney transplantation in Sicily: a benchmark analysis on activity and estimated savings 79
Reduction in bile leaks following adult split liver transplant using a fibrin-collagen sponge: A pilot study 76
Portal vein thrombosis and liver transplantation: management, matching, and outcomes: a retrospective multicenter cohort study 73
Successful treatment of systemic de novo sarcoidosis with cyclosporine discontinuation and provision of rapamune after liver transplantation 72
Saline Contrast Echocardiography in Patients With Hepatopulmonary Syndrome Awaiting Liver Transplantation 54
Case Report: E-cadherin and Vimentin expression in advanced-stage pancreatic ductal adenocarcinoma tissue and circulating tumor cells: preliminary results from a pilot study 24
null 3
Totale 20.273
Categoria #
all - tutte 54.580
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.580


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022406 0 0 0 0 19 56 37 19 50 54 29 142
2022/2023771 71 75 8 95 59 156 57 91 76 11 46 26
2023/2024251 34 11 27 10 31 59 9 2 4 10 0 54
2024/20251.797 44 300 170 87 33 130 111 50 144 165 314 249
2025/20263.154 255 135 303 361 302 110 446 394 309 235 178 126
2026/20271.183 175 127 467 339 75 0 0 0 0 0 0 0
Totale 20.273